Fifth, consideration of medical supervision is important
Oral Wegovy (Semaglutide Pill) The FDA approved the Wegovy pill in December 2025, giving patients an oral semaglutide option for weight management
The foundation of any weight management plan involves lifestyle modifications, including dietary changes, increased physical activity, and behavioural support
Disclosure Fernando Gomez-Peralta has received research support from Sanofi, Novo Nordisk, Boehringer Ingelheim, and Eli Lilly, has taken part in advisory boards for Sanofi, Novo Nordisk, and AstraZeneca Pharmaceuticals LP, and has acted as a speaker for Sanofi, Novo Nordisk, Boehringer Ingelheim, Novartis, Bristol-Myers Squibb Company, Eli Lilly, and AstraZeneca Pharmaceuticals LP
Retatrutide is one of the newest players in the GLP-1 family and shows a lot of promise
Conversely, healthy individuals may have a smoother treatment experience